PLEKHA8P1 and hepatocellular carcinoma: It would have been better to use additional HCC cell lines to support our findings, but we took a recent analysis that presented PLEKHA8P1 as a significant risk factor for survival rate in colon cancer patients [43] as support for our hypothesis.